Family Management Corp Amgen Inc Transaction History

Family Management Corp

  • $553 Million
  • Q2 2024

A detailed history of Family Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Family Management Corp holds 7,812 shares of AMGN stock, worth $2.47 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
7,812
Previous 7,671 1.84%
Holding current value
$2.47 Million
Previous $2.18 Million 11.88%
% of portfolio
0.44%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$262.75 - $319.31 $37,047 - $45,022
141 Added 1.84%
7,812 $2.44 Million
Q1 2024

May 15, 2024
BUY
$268.87 - $324.56 $90,071 - $108,727
335 Added 4.57%
7,671 $2.18 Million
Q4 2023

Feb 14, 2024
BUY
$255.7 - $288.46 $27,871 - $31,442
109 Added 1.51%
7,336 $2.11 Million
Q3 2023

Nov 14, 2023
SELL
$218.65 - $271.46 $32,360 - $40,176
-148 Reduced 2.01%
7,227 $1.94 Million
Q2 2023

Aug 14, 2023
BUY
$214.27 - $253.37 $51,639 - $61,062
241 Added 3.38%
7,375 $1.64 Million
Q1 2023

May 15, 2023
BUY
$225.79 - $275.2 $1.23 Million - $1.49 Million
5,426 Added 317.68%
7,134 $1.72 Million
Q4 2022

Feb 14, 2023
BUY
$229.03 - $291.01 $11,222 - $14,259
49 Added 2.95%
1,708 $448,000
Q3 2022

Nov 14, 2022
SELL
$224.46 - $253.15 $9,427 - $10,632
-42 Reduced 2.47%
1,659 $374,000
Q2 2022

Aug 15, 2022
SELL
$230.71 - $256.74 $118,123 - $131,450
-512 Reduced 23.14%
1,701 $414,000
Q1 2022

May 16, 2022
BUY
$219.27 - $242.57 $48,458 - $53,607
221 Added 11.09%
2,213 $535,000
Q4 2021

Feb 14, 2022
SELL
$198.88 - $227.6 $75,176 - $86,032
-378 Reduced 15.95%
1,992 $448,000
Q3 2021

Nov 15, 2021
SELL
$212.27 - $248.7 $23,986 - $28,103
-113 Reduced 4.55%
2,370 $504,000
Q2 2021

Aug 13, 2021
BUY
$233.58 - $259.14 $124,731 - $138,380
534 Added 27.4%
2,483 $605,000
Q1 2021

May 14, 2021
SELL
$221.91 - $258.6 $3,106 - $3,620
-14 Reduced 0.71%
1,949 $485,000
Q4 2020

Feb 10, 2021
BUY
$216.38 - $257.67 $22,287 - $26,540
103 Added 5.54%
1,963 $451,000
Q3 2020

Nov 13, 2020
SELL
$234.65 - $260.95 $559,405 - $622,104
-2,384 Reduced 56.17%
1,860 $473,000
Q2 2020

Aug 13, 2020
BUY
$197.81 - $242.74 $63,497 - $77,919
321 Added 8.18%
4,244 $1 Million
Q1 2020

May 06, 2020
SELL
$182.24 - $241.7 $24,420 - $32,387
-134 Reduced 3.3%
3,923 $795,000
Q4 2019

Feb 11, 2020
BUY
$189.21 - $243.2 $49,383 - $63,475
261 Added 6.88%
4,057 $978,000
Q3 2019

Nov 15, 2019
BUY
$174.11 - $208.62 $7,660 - $9,179
44 Added 1.17%
3,796 $735,000
Q3 2019

Nov 12, 2019
BUY
$174.11 - $208.62 $130,582 - $156,465
750 Added 24.98%
3,752 $726,000
Q1 2019

May 14, 2019
SELL
$180.87 - $203.88 $1.75 Million - $1.97 Million
-9,668 Reduced 76.31%
3,002 $570,000
Q4 2018

Feb 14, 2019
SELL
$178.4 - $208.25 $1.84 Million - $2.14 Million
-10,286 Reduced 44.81%
12,670 $2.47 Million
Q3 2018

Nov 13, 2018
SELL
$185.29 - $208.89 $193,998 - $218,707
-1,047 Reduced 4.36%
22,956 $4.76 Million
Q2 2018

Aug 15, 2018
BUY
$166.05 - $186.51 $233,300 - $262,046
1,405 Added 6.22%
24,003 $4.43 Million
Q1 2018

May 11, 2018
SELL
$169.43 - $198.0 $226,527 - $264,726
-1,337 Reduced 5.59%
22,598 $3.85 Million
Q4 2017

Feb 15, 2018
SELL
$168.79 - $188.59 $162,882 - $181,989
-965 Reduced 3.88%
23,935 $4.16 Million
Q3 2017

Nov 13, 2017
SELL
$167.29 - $191.0 $146,378 - $167,125
-875 Reduced 3.39%
24,900 $4.64 Million
Q2 2017

Aug 18, 2017
BUY
N/A
25,775
25,775 $4.44 Million

Others Institutions Holding AMGN

# of Institutions
3,073
Shares Held
417M
Call Options Held
7.19M
Put Options Held
6.28M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Family Management Corp Portfolio

Follow Family Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Family Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email